MATTER, in partnership with the Biomedical Advanced Research and Development Authority (BARDA), has awarded BrainCheck a grant through the Paratus Digital Health Accelerator. BrainCheck is one of three companies selected, along with Apertur.ai and CranioSense, to share more than $5M in funding to advance traumatic brain injury (TBI) solutions. The projects focus on TBI resulting from nuclear detonation and related blast events, and the funding will help each company test and validate its technology.
BrainCheck’s grant will support development of BC-RAPID (Rapid Assessment for Prehospital TBI Decision-making), a smartphone app that helps first responders identify who with a suspected head injury needs urgent care. The project runs from roughly September 2026 to September 2028.
Why this matters
After a blast or other mass-casualty event, first responders may be caring for dozens of people with possible TBI, far from a hospital and a CT scanner. Head injuries are hard to judge by appearance, and the tools available in the field today depend on trained administrators and hand scoring. Most were designed to detect concussion and offer minimal help in deciding who needs care first. Some serious injuries can go unrecognized, and hospitals can fill with people who could have been safely monitored elsewhere.
What BC-RAPID does
BC-RAPID is a short assessment that runs on a standard smartphone or tablet in two to three minutes. A brief symptom survey and a symbol-matching task gauge attention and processing speed. A coordination exercise follows, in which the user tilts the phone to keep a ball centered, and the device’s motion sensor measures balance. The app flags emergency warning signs right away and produces a low-risk or high-risk result on the device, so it works without an internet connection. It doesn’t require additional hardware or a baseline test, and a user does not need medical training.
The tool draws on the platform behind BrainCheck Assess®, an FDA-registered Class II digital cognitive assessment, which is used in more than 500 clinical practices and supported by more than 35 peer-reviewed publications. In earlier emergency department research, the two tests of BC-RAPID (symbol matching and coordination) detected acute mild TBI with roughly 70 to 80 percent sensitivity and specificity, keeping much of the accuracy of BrainCheck’s longer full battery in a fraction of the time.
This grant extends BrainCheck into some of the most demanding care settings that exist. Evidence gathered at two major trauma centers will add to the research behind objective brain health assessment, and what we learn from building a fast, device-based triage tool can inform how we serve clinicians across many kinds of care.
This project has been supported in whole or in part with federal funds from the U.S. Department of Health and Human Services; Administration for Strategic Preparedness and Response; Biomedical Advanced Research and Development Authority (BARDA), under agreement number 75A50124C00028.